Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01058135 · ClinicalTrials.gov registry record · NA
Effects of Hi-maize Resistant Starch on Insulin Sensitivity
A NA study of Insulin Resistance, sponsored by Ingredion Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT01058135: Completed NA study of Insulin Resistance, sponsored by Ingredion Incorporated.
NCT01058135 is a NA study of Insulin Resistance that has completed, run by Ingredion Incorporated. The registered enrollment target is 32 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01058135, a NA study of Insulin Resistance, has completed, sponsored by Ingredion Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effects of a dietary fiber, resistant starch, on insulin sensitivity. Low insulin sensitivity is a risk factor for some diseases including type 2 diabetes and heart disease. This study will show if consuming resistant starch can help improve insulin sensitivity in overweight and obese people.
Conditions Studied
Interventions
- OTHER Hi-maize starch (Low dose)
- OTHER Hi-maize starch (High-dose)
- OTHER Control (starch)
Study Locations (1)
Illinois
- Provident Clinical Research and Consulting, Inc - Glen Ellyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT01058135 record still lists
NCT01058135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 3 interventions - of which Hi-maize starch (Low dose) is the first listed.
NCT01058135 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01058135 about?
NCT01058135 is a clinical study titled "Effects of Hi-maize Resistant Starch on Insulin Sensitivity". The purpose of this study is to determine the effects of a dietary fiber, resistant starch, on insulin sensitivity. Low insulin sensitivity is a risk factor for some diseases including type 2 diabetes and heart disease. This study will show if consuming resistant starch can help improve insulin sens...
What is the current status of trial NCT01058135?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2010-01. Estimated completion is 2010-09.
What conditions does trial NCT01058135 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT01058135?
The interventions under investigation include: Hi-maize starch (Low dose) (OTHER), Hi-maize starch (High-dose) (OTHER), Control (starch) (OTHER).
Who is sponsoring clinical trial NCT01058135?
This trial is sponsored by Ingredion Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01058135 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01058135's enrollment target sits among peer trials
32 84th of 120 higher than 35 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia